|
|
Volumn 402, Issue 6758, 1999, Pages 107-
|
|
The increasing opacity of gene therapy
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FINANCIAL MANAGEMENT;
GENE THERAPY;
HEALTH CARE ORGANIZATION;
MEDICAL RESEARCH;
NOTE;
POLICY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
GENETICS AND REPRODUCTION;
GOVERNMENT REGULATION;
RECOMBINANT DNA ADVISORY COMMITTEE;
UNITED STATES;
ADVISORY COMMITTEES;
CONFIDENTIALITY;
DISCLOSURE;
GENE THERAPY;
GOVERNMENT REGULATION;
HUMANS;
NATIONAL INSTITUTES OF HEALTH (U.S.);
PRIVATE SECTOR;
PUBLIC OPINION;
RESEARCH SUPPORT;
TRUTH DISCLOSURE;
UNITED STATES;
|
|
EID: 34548517648
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/45865 Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|